While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

Kennedy repeatedly refused to acknowledge scientific consensus that childhood vaccines don’t cause autism and that COVID-19 vaccines saved millions of lives ...

Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.

Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

With the triad of respiratory viruses present in our day-to-day, it is recommended that individuals receive both COVID-19, flu, and occasionally RSV and MPox vaccinations. However, there is a common ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats CAMBRIDGE, MA / ACCESS ...

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.

Lougheed, said the findings of the report were “shocking” and that the information it presents to the public is “long overdue ...